Finance

Beta
Lists
EOLS:NASDAQ
Evolus Inc
$7.06
+1.73%
(+0.12) 1D
Jul 8, 1:19:16 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EOLS...
Open
$6.93
High
$7.16
Low
$6.88
Mkt. cap
464.93M
Avg. vol.
758.51K
Volume
489.23K
52-wk high
$10.20
52-wk low
$3.86
EPS
-$0.67
Beta
1.32
Shares outstanding
65.86M
No. of employees
350
Open
$6.93
High
$7.16
Low
$6.88
Mkt. cap
464.93M
Avg. vol.
758.51K
Volume
489.23K
52-wk high
$10.20
52-wk low
$3.86
EPS
-$0.67
Beta
1.32
Shares outstanding
65.86M
No. of employees
350
News stories
From sources across the web
About Evolus Inc
CEODavid Moatazedi
Employees350
Founded2012
HeadquartersNewport Beach, California, United States
SectorPharmaceutical industry
Websiteevolus.com
Analyst ratings
Based on 5 analysts giving stock ratings to EOLS in the past 3 months
Strong buy
Buy
4
Hold
1
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for EOLS in the last 3 months.
Highest
Current $7.06
$17.00 (+140.79%)
Average
$14.50 (+105.38%)
Lowest
$13.00 (+84.14%)
Analyst
Recommendation
Action
Price target
Projected
Date
Serge Belanger
Needham
Hold
Maintained
-
-
07/08/2026
Uy Ear
Mizuho Securities
Buy
Reiterated
$15.00
+112.5%
07/01/2026
Sam Eiber
BTIG
Buy
Maintained
$13.00
+84.1%
06/17/2026
Annabel Samimy
Stifel Nicolaus
Buy
Maintained
$17.00
+140.8%
05/05/2026
Douglas Tsao
H.C. Wainwright
Buy
Maintained
$13.00
+84.1%
05/05/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
69.39M
68.97M
90.30M
73.14M
Cost of goods sold
24.07M
23.13M
31.01M
24.24M
Cost of revenue
24.07M
23.13M
31.01M
24.24M
Research and development expenses
1.84M
2.05M
3.48M
2.24M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
56.68M
52.82M
54.66M
51.98M
Operating expense
59.44M
56.00M
59.58M
55.76M
Total operating expenses
83.51M
79.13M
90.59M
80.00M
Operating income
-14.12M
-10.16M
-291.00K
-6.86M
Other non operating income
-151.00K
-455.00K
10.00K
120.00K
EBT including unusual items
-17.09M
-15.57M
515.00K
-10.42M
EBT excluding unusual items
-21.00M
-14.23M
-4.00M
-10.43M
Income tax expense
53.00K
167.00K
385.00K
256.00K
Effective tax rate
-0.31%
-1.07%
74.76%
-2.46%
Other operating expenses
-
-
-
-
Net income
-17.14M
-15.74M
130.00K
-10.67M
Net profit margin
-24.70%
-22.82%
0.14%
-14.59%
Earnings per share
-0.26
-0.15
0.01
-0.05
Interest and investment income
479.00K
479.00K
263.00K
285.00K
Interest expense
-7.21M
-4.09M
-3.98M
-3.98M
Net interest expenses
-6.73M
-3.62M
-3.72M
-3.69M
Depreciation and amortization charges
932.00K
1.14M
1.45M
1.54M
EBITDA
-12.39M
-8.21M
1.96M
-4.52M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer